Enhanced sensitivity of pancreatic cells to cholecystokinin octapeptide in obstructive jaundice.
Exocrine function of the pancreas in obstructive jaundice was examined using dogs. Jaundice induced by choledochal ligation over 3 weeks showed pancreatic hypersecretion in response to cholecystokinin octapeptide (CCK-8) stimulation. To clarify the mechanism of pancreatic hypersecretion in obstructive jaundice, three experiments were undertaken. In a perfusion experiment performed on isolated pancreas, hypersecretion in obstructive jaundice was observed in response to CCK-8 stimulation. An incubation experiment showed an increase in secretion in response to CCK-8 stimulation in a dose-dependent manner, producing a greater increase in dogs with obstructive jaundice than in controls, despite the fact that basal secretion in both groups was the same. This would suggest that at least one of the mechanisms of pancreatic hypersecretion in obstructive jaundice may be related to the degree of sensitivity of acinar cells to CCK-8. In morphological observation of acinar cells by electron microscopy, the average number of zymogen granules and total granular area per unit of cytoplasm in both groups before and after stimulation with CCK-8 were compared. There was no difference between the groups before stimulation. Following stimulation, values for the control group decreased but appeared to increase in the jaundiced pancreas. These results strongly suggest that pancreatic acinar cells in obstructive jaundice may retain their secretory potential after stimulation for 60 min, though the potential in nonjaundiced pancreatic acinar cells may decrease after stimulation.
Kuroda
T
T
Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Shiohara
E
E
Hanazaki
K
K
Haba
Y
Y
Iida
F
F
D000818:Animals; D002478:Cells, Cultured; D002779:Cholestasis / Q000473:pathology / Q000503:physiopathology*; D004285:Dogs; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D010179:Pancreas / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010477:Perfusion; D012016:Reference Values; D012844:Sincalide / Q000494:pharmacology*
D012844:Sincalide